Dr. Bommakanti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
701 Park Ave
Minneapolis, MN 55415Phone+1 612-873-6369Fax+1 612-904-4341
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 2008 - 2011
Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 2005 - 2008
Tulane University School of MedicineClass of 2005
Certifications & Licensure
MN State Medical License 2009 - 2025
WI State Medical License 2007 - 2023
LA State Medical License 2011 - 2012- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 8 citationsCase reports: efalizumab-associated lymphoproliferative disease.Satya Bommakanti, Amol Patil, Camellia Eshoa, Christopher R. Chitambar
Journal of Drugs in Dermatology. 2007-06-01 - 7 citationsPhase 1 trial of gemcitabine with bortezomib in elderly patients with advanced solid tumors.Satya V. Bommakanti, Arkadiusz Z. Dudek, Amit Khatri, Mark N. Kirstein, Purvi Gada
American Journal of Clinical Oncology. 2011-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
